Codexis Inc. (CDXS)

전일 마감가:

$3.34

열려 있는:

$3.62

하루 거래량:

1.70M

시가총액:

$276.59M

수익:

$70.14M

순이익/손실:

$-76.24M

주가수익비율:

-4.6118

EPS:

-0.85

순현금흐름:

$-57.06M

1주 성능:

+47.37%

1개월 성능:

+17.37%

6개월 성능:

+103.11%

1년 성능:

-4.16%

1일 변동 폭

$3.53

$4.01

52주 변동 폭

$1.45

$4.91

Codexis Inc. Stock (CDXS) Company Profile

명칭

Codexis Inc.

부문

Healthcare (1213)

산업

Biotechnology (699)

전화

650-421-8100

주소

200 Penobscot Drive, Redwood City, CA

직원

116

트위터

@codexisinc

다음 수익 날짜

2024-05-02

최신 SEC 제출 서류

CDXS's Discussions on Twitter

Codexis Inc. Stock (CDXS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-05-09	다운그레이드	H.C. Wainwright	Buy → Neutral
2022-03-31	재개	Piper Sandler	Overweight
2022-03-02	재개	Cowen	Outperform
2021-04-12	개시	Piper Sandler	Overweight
2021-03-01	개시	Stifel	Buy
2021-02-26	재확인	H.C. Wainwright	Buy
2020-03-10	개시	The Benchmark Company	Buy
2019-01-17	업그레이드	First Analysis Sec	Neutral → Outperform
2018-05-16	개시	Stephens	Overweight
2017-10-13	재확인	H.C. Wainwright	Buy
2017-05-31	개시	Jefferies	Buy
2017-01-26	다운그레이드	First Analysis Sec	Overweight → Equal-Weight
2017-01-04	업그레이드	Ladenburg Thalmann	Neutral → Buy
2016-01-06	개시	H.C. Wainwright	Buy

모두보기

Codexis Inc. 주식(CDXS)의 최신 뉴스

Codexis to Report First Quarter 2024 Financial Results on May 2

GlobeNewswire Inc.

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

GlobeNewswire Inc.

Codexis (CDXS) Tops Q4 Earnings and Revenue Estimates

Zacks Investment Research

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

GlobeNewswire Inc.

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

GlobeNewswire Inc.

Codexis Inc. (CDXS) 재무 분석

Codexis Inc. (CDXS) 매출 2024

Codexis Inc. (CDXS) 순이익 2024

Codexis Inc. (CDXS) 현금흐름 2024

Codexis Inc. (CDXS) 주당 순이익 2024